Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 2 | Acta Veterinaria Scandinavica

Figure 2

From: Evaluation of multicomponent recombinant vaccines against Actinobacillus pleuropneumoniae in mice

Figure 2

Histopathology of lungs from mice in various groups after challenge with APP1 or APP2 (HE staining 200 × magnification). 2a: Control group challenged with APP1; 2b: Group I challenged with APP1; 2c: Group II challenged with APP1; 2d: Group III challenged with APP1; 2e: Control group challenged with APP2; 2f: Group I challenged with APP 2; 2g: Group II challenged with APP2; 2h: Group III challenged with APP2.

Back to article page